HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics, pharmacodynamics and local tolerance at injection site of marbofloxacin administered by regional intravenous limb perfusion in standing horses.

AbstractOBJECTIVE:
To evaluate pharmacokinetic-pharmacodynamic variables and local tolerance at injection-site of marbofloxacin administered via regional intravenous limb perfusion (RIVLP) in standing horses.
ANIMALS:
Adult horses (n = 6).
METHODS:
RIVLP were performed with rubber tourniquets applied to the forelimbs of standing sedated horses. Marbofloxacin (0.67 mg/kg) was randomly injected in 1 forelimb, with the contralateral limb serving as a control (0.9% NaCl solution). Samples of jugular blood and synovial fluid from the radiocarpal joint of the marbofloxacin-perfused limb were collected before and at intervals after RIVLP for determination of drug concentrations. All injection sites were evaluated before, 24 and 48 hours after RIVLP by means of ultrasonographic examination, circumferential measurements and subjective visible inflammation scores by veterinarians unaware of treatment received.
RESULTS:
No adverse effects associated with the technique or antibiotic were observed. High marbofloxacin concentrations were obtained in the synovial fluid, AUCINF was significantly higher in synovial fluid than in plasma (78.64 ± 49.41 and 2.85 ± 0.60 µg h/mL respectively, P = .028). The efficacy indices, AUC0-24 /MIC90 and Cmaxobs/MIC90 , predicted a favorable outcome in the treatment of synovial fluid infections caused by enterobacteriaceae and Staphylococcus aureus. After RIVLP, there was no statistically significant difference between marbofloxacin-injected and control limbs for lameness, visual inflammation score, limb circumference, and ultrasonographic appearance of the veins. Marbofloxacin injected limbs had a significantly greater subcutaneous thickness, compared with control limbs.
CONCLUSIONS:
These data suggest that RIVLP of marbofloxacin (0.67 mg/kg) could be a safe and effective method for treatment of infections of the distal portion of the limb for susceptible organisms.
AuthorsElodie Lallemand, Pierre Trencart, Carine Tahier, Frederic Dron, Angelique Paulin, Caroline Tessier
JournalVeterinary surgery : VS (Vet Surg) Vol. 42 Issue 6 Pg. 649-57 (Aug 2013) ISSN: 1532-950X [Electronic] United States
PMID23889562 (Publication Type: Journal Article)
Copyright© Copyright 2013 by The American College of Veterinary Surgeons.
Chemical References
  • Anti-Bacterial Agents
  • Fluoroquinolones
  • marbofloxacin
Topics
  • Animals
  • Anti-Bacterial Agents (administration & dosage, pharmacokinetics, pharmacology)
  • Area Under Curve
  • Female
  • Fluoroquinolones (administration & dosage, pharmacokinetics, pharmacology)
  • Forelimb (metabolism)
  • Horses (metabolism)
  • Infusions, Intravenous (veterinary)
  • Synovial Fluid (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: